To download the current issue of HIT Perpectives Biopharma Insights via PDF, please click the thumbnail image to the right.
Innovations in Formulary, Benefit and Eligibility To Transform the Point of Care Experience | Four Factors Driving the Momentum of Telehealth Adoption That Will Continue After the COVID-19 Crisis | Post COVID-19: Five Things That Will Come Roaring Back With a Twist
The Critical Role of Health IT in Fighting COVID-19 | Five Predictions on How the COVID-19 Crisis Will Transform Health IT | Take Note of the Health IT Opportunities Emerging From the Final Interoperability Rules of ONC and CMS
How Account Teams Can Help Ambulatory Physicians Succeed in the Era of Value-Based Care |Improving Drug Price Transparency: The Case for Out-of-Pocket Drug Cost Information at the Point of Prescribing | Thumbs Up at this ePrescribing Checkpoint!
Following What the Doctor Ordered: Addressing Medication Noncompliance | The Impact of New, Nonproprietary Naming Convention for Biologics and Biosimilars: 7 Key Findings | ONC to Significantly Scale Back EHR Certification and Enrollment
Why Population Health Management Should Matter to Pharmaceutical Manufacturers | HHS Moves Ahead in Personnel and Health IT | New Maturity Model Will Help Spur Adoption of Electronic Prior Authorization
Working Smarter, Not Harder: Helping Clinicians Optimize Use of EHRs | Computerized Order Sets Help Physicians Save Time and Improve Care | Electronic Dosing Instructions: Opportunities for Sales Teams
New Proposed Regulation Rebrands and Retools Meaningful Use | Cutting Through the Confusion Surrounding Electronic Formulary and Benefit Checks | Retail Medical Clinics: Untapped Resources for Patient Education
Biosimilars: Opportunity Knocks – Building a Better Technology Mousetrap | Improved Prescription Information: The Key to Closing the Medication Adherence Gap | Drug Databases: A Growing Resource for Patient Care and Safety